...
首页> 外文期刊>The Journal of Neuroscience: The Official Journal of the Society for Neuroscience >The Transient Receptor Potential Melastatin 2 (TRPM2) Channel Contributes to beta-Amyloid Oligomer-Related Neurotoxicity and Memory Impairment
【24h】

The Transient Receptor Potential Melastatin 2 (TRPM2) Channel Contributes to beta-Amyloid Oligomer-Related Neurotoxicity and Memory Impairment

机译:瞬时受体潜在的melastatin 2(TRPM2)通道有助于β-淀粉样寡聚体相关的神经毒性和记忆障碍

获取原文
获取原文并翻译 | 示例
           

摘要

In Alzheimer's disease, accumulation of soluble oligomers of beta-amyloid peptide is known to be highly toxic, causing disturbances in synaptic activity and neuronal death. Multiple studies relate these effects to increased oxidative stress and aberrant activity of calcium-permeable cation channels leading to calcium imbalance. The transient receptor potential melastatin 2 (TRPM2) channel, a Ca2+-permeable nonselective cation channel activated by oxidative stress, has been implicated in neurodegenerative diseases, and more recently in amyloid-induced toxicity. Here we show that the function of TRPM2 is augmented by treatment of cultured neurons with beta-amyloid oligomers. Aged APP/PS1 Alzheimer's mouse model showed increased levels of endoplasmic reticulum stress markers, protein disulfide isomerase and phosphorylated eukaryotic initiation factor 2 alpha, as well as decreased levels of the presynaptic marker synaptophysin. Elimination of TRPM2 in APP/PS1 mice corrected these abnormal responses without affecting plaque burden. These effects of TRPM2 seem to be selective for beta-amyloid toxicity, as ER stress responses to thapsigargin or tunicamycin in TRPM2(-/-) neurons was identical to that of wild-type neurons. Moreover, reduced microglial activation was observed in TRPM2(-/-)/APP/PS1 hippocampus compared with APP/PS1 mice. In addition, age-dependent spatial memory deficits in APP/PS1 mice were reversed in TRPM2(-/-)/APP/PS1 mice. These results reveal the importance of TRPM2 for beta-amyloid neuronal toxicity, suggesting that TRPM2 activity could be potentially targeted to improve outcomes in Alzheimer's disease.
机译:在阿尔茨海默氏病中,β-淀粉样肽的可溶性寡聚体的积累被认为具有剧毒,会引起突触活性和神经元死亡。多项研究将这些影响与增加的氧化应激和导致钙不平衡的钙可渗透阳离子通道的异常活性联系起来。瞬时受体电位褪黑素2(TRPM2)通道是由氧化应激激活的可透过Ca2 +的非选择性阳离子通道,与神经退行性疾病有关,最近与淀粉样蛋白诱导的毒性有关。在这里,我们显示,通过使用β-淀粉样蛋白寡聚体处理培养的神经元,可以增强TRPM2的功能。老年APP / PS1阿尔茨海默氏症小鼠模型显示内质网应激标志物,蛋白质二硫键异构酶和磷酸化的真核生物起始因子2α水平升高,以及突触前标志突触素水平降低。消除APP / PS1小鼠中的TRPM2可纠正这些异常反应,而不影响菌斑负担。 TRPM2的这些作用似乎对β-淀粉样蛋白毒性具有选择性,因为TRPM2(-/-)神经元中对毒胡萝卜素或衣霉素的内质网应激反应与野生型神经元相同。此外,与APP / PS1小鼠相比,TRPM2(-/-)/ APP / PS1海马中观察到的小胶质细胞活化减少。此外,APP / PS1小鼠的年龄依赖性空间记忆缺陷在TRPM2(-/-)/ APP / PS1小鼠中被逆转。这些结果揭示了TRPM2对于β淀粉样蛋白神经元毒性的重要性,这表明TRPM2活性可能被潜在地用于改善阿尔茨海默氏病的预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号